Cardlytics Q4 revenue $89.2M (+8.1% YoY); first full-year positive Adjusted EBITDA since 2019

Cardlytics, Inc.

Q4 revenue $89.2M (+8.1% YoY); full-year revenue $309.2M (+3.6% YoY).
Q4 Adjusted EBITDA $10.0M vs ($6.1M) YoY; full-year Adj EBITDA $3.8M vs ($45.2M), first positive since 2019.
Net loss narrowed: Q4 ($100.8M) vs ($378.3M); FY ($134.7M) vs ($465.3M).
Q1 2024 guidance: billings $105-109M, revenue $70-73M, Adj EBITDA ($1M)-$1M.
Monthly active users 168.0M in Q4, +7.1% YoY; full-year ARPU $1.91, -1.3%.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cardlytics, Inc. reported financial results for fourth quarter and full year ended December 31, 2023.

Period: fourth quarter and full year ended December 31, 2023
Result: reported results

Exact text from the filing

Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-24-000034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.